Sunday 12 July 2015

Charles River to Acquire Celsis

A news post from Charles River, of relevance to rapid microbiological methods.

Charles River has announced plans to acquire Celsis International Ltd. Celsis is a leading provider of rapid microbial detection systems for quality control testing in the biopharmaceutical and consumer products industries. This acquisition complements Charles River's Endotoxin and Microbial Detection business, which is a leading provider of rapid endotoxin testing systems and bacterial identification services for biopharmaceutical manufacturing, creating the most comprehensive solution for rapid quality control testing of biopharmaceutical and consumer products.

The addition of Celsis, with its Advance II™, Accel™ and Innovate™ systems, will complement Charles River's recently introduced PTS-Micro™, a rapid bacterial detection system for biopharmaceutical applications. The combination of Charles River and Celsis will drive significant value for our clients' in-process and product release testing needs across a broad range of microbial detection applications.


Posted by Tim Sandle

No comments:

Post a Comment

Pharmaceutical Microbiology Resources

Special offers